0001779372-23-000017.txt : 20230609
0001779372-23-000017.hdr.sgml : 20230609
20230609195912
ACCESSION NUMBER: 0001779372-23-000017
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230514
FILED AS OF DATE: 20230609
DATE AS OF CHANGE: 20230609
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Persen Kenneth Harry
CENTRAL INDEX KEY: 0001942350
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41060
FILM NUMBER: 231006826
MAIL ADDRESS:
STREET 1: 2118 WALSH AVENUE, SUITE 210
CITY: SANTA CLARA
STATE: CA
ZIP: 95050
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HeartBeam, Inc.
CENTRAL INDEX KEY: 0001779372
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 474881450
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2118 WALSH AVE., SUITE 210
CITY: SANTA CLARA
STATE: CA
ZIP: 95050
BUSINESS PHONE: 408-899-4443
MAIL ADDRESS:
STREET 1: 2118 WALSH AVE., SUITE 210
CITY: SANTA CLARA
STATE: CA
ZIP: 95050
4
1
wk-form4_1686355142.xml
FORM 4
X0407
4
2023-05-14
0
0001779372
HeartBeam, Inc.
BEAT
0001942350
Persen Kenneth Harry
2118 WALSH AVENUE, SUITE 210
SANTA CLARA
CA
95050
0
1
0
0
Chief Technology Officer
0
Stock option (right to buy)
2023-05-14
4
A
0
169000
0
A
2033-05-13
Common Stock
169000
169000
D
The exercise price per share of each option (?Option? and collectively, the ?Options?) shall be the Fair Market Value (as defined in the Company?s 2022 Equity Incentive Plan) of a share as of May 14, 2023.
The Options have been issued from the Company's 2022 Equity Incentive Plan, that was approved by the Members of the Board of Directors on May 14, 2023.
The Options will vest and become exercisable with respect to 40% of the shares starting May 14, 2023, with one forty-eighth (1/48th) of the shares vesting each calendar month thereafter on the same day of the month as the first vesting date. The remaining 60% of the shares will vest and become exercisable once HeartBeam, Inc. receives FDA Clearance for marketing of HeartBeam?s synthesized 12-Lead product obtained by signal synthesis from the recorded xyz signals.
/s/ Kenneth Persen
2023-06-09